By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing machine on Monday, marking a bid by the Swiss drugmaker and diagnostics ...
Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance?
Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers Squibb’s Krazati in a phase 3 trial, furthering its ambitions to establish divarasib as a new standard of care ...
Valve opened Steam Machine pre-orders on the back of its price and release date announcements for the PC-console hybrid. The situation is much like it was for the Steam Deck, with limited availability ...
Roche's chief medical officer, Levi Garraway. Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new phase 3 data for its experimental KRAS G12C inhibitor, divarasib, which it ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist’s market share with its own next-gen platform. Roche’s Axelios 1 delivers ...
The Steam Machine is finally here after looming on the horizon for the last eight months or so. And while Valve has been adamant that the Steam Machine is an entry-level gaming PC, rather than a new, ...
After months of speculation, the Steam Machine is finally here, starting at $1049 for the 512GB version. If that price is still within your budget, you can reserve it now on Steam. That $1049 is just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results